| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
389,580,000 |
| Market
Cap: |
45.17(B) |
| Last
Volume: |
1,813,692 |
Avg
Vol: |
1,929,144 |
| 52
Week Range: |
$75.49 - $140.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 487 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
64,005 |
267,979 |
302,595 |
574,627 |
| Total Sell Value |
$8,769,441 |
$35,482,928 |
$39,449,301 |
$69,910,840 |
| Total People Sold |
6 |
8 |
13 |
15 |
| Total Sell Transactions |
10 |
24 |
47 |
82 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-03-08 |
4 |
A |
$0.00 |
$36 |
D/D |
35,829 |
344,666 |
|
- |
|
| Balo Andrew K |
* |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$15 |
D/D |
14,987 |
88,134 |
|
- |
|
| Leach Jacob Steven |
EVP Chief Technology Officer |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$15 |
D/D |
14,987 |
124,638 |
|
- |
|
| Blackford Quentin S. |
EVP Chief Financial Officer |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$18 |
D/D |
18,432 |
105,972 |
|
- |
|
| Ace Heather S |
SVP Human Resources |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$12 |
D/D |
11,714 |
76,795 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$16 |
D/D |
16,365 |
83,381 |
|
- |
|
| Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
• – – |
2019-02-22 |
4 |
AS |
$140.50 |
$241,157 |
D/D |
(1,667) |
99,737 |
|
- |
|
| Foletta Mark G |
Director |
– • – |
2019-02-15 |
4 |
AS |
$148.52 |
$148,723 |
I/I |
(1,000) |
16,095 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-02-11 |
4 |
AS |
$148.14 |
$893,400 |
D/D |
(6,000) |
308,837 |
|
- |
|
| Murphy Patrick Michael |
SVP Legal Affairs |
• – – |
2019-02-08 |
4 |
AS |
$142.76 |
$57,104 |
D/D |
(400) |
29,308 |
|
- |
|
| Pacelli Steven Robert |
EVP, Strategy & Corp. Dev. |
• – – |
2019-01-23 |
4 |
AS |
$149.74 |
$466,303 |
D/D |
(3,114) |
101,404 |
|
- |
|
| Kahn Barbara |
Director |
– • – |
2019-01-14 |
4 |
AS |
$141.16 |
$1,512,827 |
I/I |
(10,631) |
16,817 |
|
- |
|
| Sayer Kevin R |
President, CEO & Chairman |
• • – |
2019-01-14 |
4 |
AS |
$140.91 |
$845,930 |
D/D |
(6,000) |
314,837 |
|
- |
|
| Murphy Patrick Michael |
SVP, GC & Chief Compliance Off |
• – – |
2019-01-10 |
4 |
AS |
$138.75 |
$55,500 |
D/D |
(400) |
29,708 |
|
- |
|
| Altman Steven R |
Director |
– • – |
2019-01-02 |
4 |
AS |
$117.04 |
$292,593 |
I/I |
(2,500) |
52,855 |
|
- |
|
| Skyler Jay S |
Director |
– • – |
2019-01-02 |
4 |
OE |
$4.58 |
$118,191 |
I/I |
25,806 |
52,616 |
|
- |
|
| Doubleday Richard |
EVP, Chief Commercial Officer |
• – – |
2018-12-21 |
4 |
AS |
$108.23 |
$165,101 |
I/I |
(1,510) |
14,112 |
|
- |
|
| Pacelli Steven Robert |
EVP, Strategy & Corp. Dev. |
• – – |
2018-12-21 |
4 |
AS |
$108.24 |
$340,700 |
D/D |
(3,114) |
104,518 |
|
- |
|
| Balo Andrew K |
EVP, Reg. Strategy, Clinical |
• – – |
2018-12-14 |
4 |
AS |
$120.23 |
$606,167 |
D/D |
(5,000) |
73,105 |
|
- |
|
| Murphy Patrick Michael |
SVP, GC & Chief Compliance Off |
• – – |
2018-12-10 |
4 |
AS |
$121.90 |
$48,760 |
D/D |
(400) |
30,108 |
|
- |
|
| Sayer Kevin R |
President, CEO & Chairman |
• • – |
2018-12-10 |
4 |
AS |
$120.39 |
$1,358,041 |
D/D |
(11,162) |
320,837 |
|
- |
|
| Sayer Kevin R |
President, CEO & Chairman |
• • – |
2018-12-10 |
4 |
OE |
$4.58 |
$51,122 |
D/D |
11,162 |
331,999 |
|
- |
|
| Doubleday Richard |
EVP, Chief Commercial Officer |
• – – |
2018-11-23 |
4 |
AS |
$119.74 |
$210,664 |
I/I |
(1,736) |
15,622 |
|
- |
|
| Pacelli Steven Robert |
EVP, Strategy & Corp. Dev. |
• – – |
2018-11-23 |
4 |
AS |
$119.82 |
$378,105 |
D/D |
(3,114) |
107,632 |
|
- |
|
| Balo Andrew K |
EVP, Reg. Strategy, Clinical |
• – – |
2018-11-14 |
4 |
AS |
$141.25 |
$715,664 |
D/D |
(5,000) |
78,105 |
|
- |
|
2306 Records found
|
|
Page 28 of 93 |
|
|
2.14 (1.88%) 
